 |
市场调查报告书
商品编码
1550577
全球支气管炎治疗市场：按类型、按治疗方法、按药物类别、按给药途径、按分销管道、按地区Global Bronchitis Treatment Market, By Type, By Treatment, By Drug Class, By Route of Administration, By Distribution Channel, By Geography |
||||||
预计2024年全球支气管炎治疗市场规模将达82.2亿美元，2024年至2031年复合年增长率为5.3%，2031年将达118.1亿美元。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 82.2亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 5.30% | 2031 年金额预测 | 118.1亿美元 |
支气管炎是将空气输送到肺部的支气管或空气通道的发炎。它会导致咳嗽、气喘和呼吸短促。由于呼吸道疾病的增加，全球支气管炎治疗市场可能会成长。全球污染水平上升、烟草消费量和生活习惯改变可能为市场成长提供机会。医学进步也扩大了急性和慢性支气管炎患者的治疗选择。
市场动态：
全球支气管炎治疗市场的成长是由污染水平上升、人口老化和烟草消费量增加等因素所推动的。碳排放的增加导致空气品质恶化，空气中粒状物增加，导致呼吸道感染疾病上升。此外，随着时间的推移，香烟和其他烟草製品会损害肺组织，使您更容易患支气管炎。然而，有关烟草产品的严格法规和健康意识的提高可能会阻碍市场成长。数位健康工具和远端监控设备的采用可以为远端医疗服务提供机会，以更有效地管理支气管炎护理。
本研究的主要特点
本报告对全球支气管炎治疗市场进行了详细分析，包括以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，包括全球支气管炎治疗市场的主要企业概况。
研究涵盖的主要企业包括辉瑞、葛兰素史克、赛诺菲安万特、勃林格殷格翰、安斯泰来製药、拜耳等。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球支气管炎治疗市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球支气管炎治疗市场的各种策略矩阵，将促进相关人员的决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章 市场动态、法规与趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球支气管炎治疗市场－COVID-19 的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球支气管炎治疗市场，按类型，2019-2031（十亿美元）
- 急性支气管炎
- 慢性支气管炎
第六章 全球支气管炎治疗市场，依治疗方法，2019-2031（十亿美元）
- 毒品
- 氧气疗法
第七章 全球支气管炎治疗市场，依药物类别，2019-2031（十亿美元）
- 发炎药
- 抗生素
- 支气管扩张剂
- 溶血剂
第 8 章 全球支气管炎治疗市场，依给药途径，2019-2031 年（十亿美元）
- 口服
- 胃肠外的
- 吸入器/滴鼻剂
- 其他的
第9章全球支气管炎治疗市场，按分销管道，2019-2031（十亿美元）
- 网路药房
- 零售药房
- 医院药房
第10章全球支气管炎治疗市场，按地区，2019-2031（十亿美元）
- 拉丁美洲
- 欧洲
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第十一章竞争格局
- 公司简介
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Merck &Co.
- Pfizer
- Teva Pharmaceutical Industries
- Sanofi
- Roche
- Johnson &Johnson
- Mylan NV
- Gilead Sciences
- AbbVie
- Bausch Health Companies
- Hikma Pharmaceuticals
- Amgen
- Sumitomo Dainippon Pharma
- Eli Lilly and Company
第十二章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十三章参考文献与调查方法
- 参考
- 调查方法
Global bronchitis treatment market is estimated to be valued at USD 8.22 Bn in 2024 and is expected to reach USD 11.81 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 8.22 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 5.30% | 2031 Value Projection: | US$ 11.81 Bn |
Bronchitis is an inflammation of the bronchi or air passages that carry air to the lungs. It causes coughing, wheezing and shortness of breath. Global bronchitis treatment market can witness growth due to rising rates of respiratory illnesses. Increasing pollution levels, tobacco consumption and changing lifestyle habits across the world can offer market growth opportunities. Advancements in medicine have also expanded treatment options available to patients suffering from both acute and chronic bronchitis.
Market Dynamics:
Global bronchitis treatment market growth is driven by factors such as rising pollution levels, aging population and growing tobacco consumption. Increased carbon emissions have deteriorated air quality and more particulate matter in the air leads to higher incidences of respiratory infections. Furthermore, cigarettes and other tobacco products damage lung tissues over time and make people more susceptible to bronchitis. However, stringent regulations around tobacco products and higher health awareness can hamper the market growth. Adoption of digital health tools and remote monitoring devices can offer opportunity for telehealth services to manage bronchitis care more efficiently.
Key Features of the Study:
This report provides in-depth analysis of the global bronchitis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bronchitis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, GlaxoSmithKline, Sanofi Aventis, Boehringer Ingelheim, Astellas Pharma and Bayer
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global bronchitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bronchitis treatment market
Detailed Segmentation-
- By Type:
- Acute Bronchitis
- Chronic Bronchitis
- By Treatment
- Drugs
- Oxygen Therapy
- By Drug Class
- Anti-Inflammatory Drugs
- Antibiotics
- Bronchodilators
- Mucolytic
- By Route of Administration
- Oral
- Parenteral
- Inhalers/Nasal sprays
- Others
- By Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Merck & Co.
- Pfizer
- Teva Pharmaceutical Industries
- Sanofi
- Roche
- Johnson & Johnson
- Mylan N.V.
- Gilead Sciences
- AbbVie
- Bausch Health Companies
- Hikma Pharmaceuticals
- Amgen
- Sumitomo Dainippon Pharma
- Eli Lilly and Company
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Bronchitis Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Bronchitis Treatment Market, By Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Acute Bronchitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic Bronchitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Bronchitis Treatment Market, By Treatment, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Oxygen Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Bronchitis Treatment Market, By Drug Class, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Anti-Inflammatory Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Bronchodilators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Mucolytic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Bronchitis Treatment Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inhalers/Nasal sprays
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Bronchitis Treatment Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
10. Global Bronchitis Treatment Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- GlaxoSmithKline
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Boehringer Ingelheim
- Novartis
- Merck & Co.
- Pfizer
- Teva Pharmaceutical Industries
- Sanofi
- Roche
- Johnson & Johnson
- Mylan N.V.
- Gilead Sciences
- AbbVie
- Bausch Health Companies
- Hikma Pharmaceuticals
- Amgen
- Sumitomo Dainippon Pharma
- Eli Lilly and Company
- GlaxoSmithKline
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
